Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model

• Published in: Cancer chemotherapy and pharmacology 1995, Vol.36 (4), p.283-289
• Main Authors: EKSTRØM, P. O, ANDERSEN, A, WARREN, D. J, GIERCKSKY, K. E, SLØRDAL, L
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Biological and medical sciences; Chromatography, High Pressure Liquid; Extracellular Space - metabolism; General aspects; Kidney - metabolism; Liver - metabolism; Male; Medical sciences; Methotrexate - administration & dosage; Methotrexate - blood; Methotrexate - pharmacokinetics; Microdialysis; Models, Biological; Muscle, Skeletal - metabolism; Pharmacology. Drug treatments; Rats; Rats, Wistar; Tissue Distribution
• ISSN: 0344-5704; 1432-0843
• DOI: 10.1007/BF00689044

We used a microdialysis technique to monitor extracellular methotrexate (MTX) levels during the steady state in a rodent model. Microdialysis probes were implanted in the muscle, liver, and kidney of anesthetized male Wistar rats. MTX (18.75-500 mg/kg) was given as a continuous infusion through a venous catheter, and blood samples were obtained through a second venous catheter. Heparinized plasma, ultrafiltered plasma, microdialysis effluent from tissues, and tissue samples (obtained at the end of experiments) were analyzed for MTX content by high-performance liquid chromatography (HPLC). Steady state was demonstrated in the blood and tissues from 2 h until the end of the experiments (6 h). Extracellular drug levels in muscle and liver displayed a linear correlation with doses, whereas kidney levels reached a plateau at an MTX dose of 150 mg/kg per 6 h. Microdialysis-fluid endpoint levels for muscle, liver, and kidney were positively correlated to the endpoint total tissue levels (r2 = 0.80, 0.85, and 0.68, respectively). In the kidneys, the maximal relative tissue MTX accumulation was measured at a total dose of 75 mg/kg per 6 h. At higher doses, the relative drug sequestration declined to less than half of the values observed at this dose. This study demonstrates that the microdialysis technique can provide reproducible data on MTX tissue exposure in an animal model and that it offers a means of serial and reproducible monitoring of extracellular-tissue MTX levels at steady state and over a wide dose range. Pending additional studies, microdialysis may be a helpful technique for elucidating the kinetics of drug delivery to both targeted and toxicity-prone tissues during chemotherapy.